Researchers work to uncover new information on long-term use of obesity medications
UC expert shares her insight with MedCentral site for health care professionals
A new chapter in obesity care has emerged. In addition to recently approved medications used for weight management — the GLP-1 receptor agonists — several additional pharmacotherapies are in the works. These treatments are said to offer more effective solutions for long-term obesity management. Yet details on the impact of long-term use are still being uncovered.
“Several randomized, controlled trials show that all FDA-approved anti-obesity medications are safe and effective for long-term use when prescribed responsibly to the appropriate patient population, based on individualized health risk assessment,” said Malti Vij, MD, adjunct assistant professor of internal medicine at the University of Cincinnati College of Medicine for a MedCentral article. “For an effective weight loss intervention, physicians must prescribe anti-obesity medications alongside counseling, lifestyle changes, regular monitoring and follow-ups, as with other chronic conditions."
Before prescribing GLP-1 medications for weight loss, physicians are advised to educate their patients on long-term use.
“For better adherence, choose the right anti-obesity medication for the right patient. This involves carrying out a comprehensive patient assessment in terms of their weight loss expectations, followed by careful consideration of the medication side effects, long-term safety and cost-effectiveness,” Vij explained.
Click here to read the entire MedCentral article on obesity medications.
Featured image at top: Dosing pen for subcutaneous injection of anti-obesity medication. Photo/istock/aprott.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.